Printer Friendly

BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT

 BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
 ST. PAUL, Minn., Oct. 6 /PRNewswire/ -- Bioplasty, Inc.


(NASDAQ-NMS: BIOP) announced today that it has settled the lawsuit brought by Mentor Corporation (NASDAQ-NMS: MNTR) alleging infringement on two of its patents relating to mammary implants.
 Pursuant to the terms of the settlement agreement, Bioplasty, Inc. and Mentor Corporation have agreed to cross-license Bioplasty's United States Patent No. 4,955,909 (textured silicone shell) and Mentor's United States Patent No. 4,960,425 (textured silicone shell). Also, Mentor Corporation and Bioplasty, Inc. agree to cause their respective counsel to execute and file the Stipulation of Dismissal without Prejudice for the alleged infringement of Mentor's United States Patent No. 4,731,081. It is understood by both companies that they do not admit any liability on the claims asserted in the lawsuit.
 Bioplasty, Inc. has more than 20 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ National Market System under the symbol BIOP.
 -0- 10/6/92
 /CONTACT: Timothy P. Lawin, president, Bioplasty, 612-636-4112/
 (BIOP MNTR) CO: Bioplasty, Inc.; Mentor Corporation ST: Minnesota IN: MTC SU:


KH -- MN008 -- 7089 10/06/92 12:49 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 6, 1992
Words:201
Previous Article:ENHANCE GROUP NAMES GRATIA D. PELLICIOTTI VICE PRESIDENT, MANAGER OF SURVEILLANCE DIVISION
Next Article:NIKE AND JAZZERCISE JUST DO IT
Topics:


Related Articles
INAMED BRINGS PATENT INFRINGEMENT SUIT AGAINST BIOPLASTY
BIOPLASTY, INC., ANNOUNCES RECEIPT OF PATENT INFRINGEMENT COMPLAINT
BIOPLASTY LICENSES SYNTHETIC WOUND CARE DRESSING
BIOPLASTY AGREES TO PROPOSED SETTLEMENT OF SHAREHOLDERS' SUIT
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIO-VASCULAR REPORTS DISPUTE ON ROYALTIES
BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED
BIOPLASTY, INC. ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER
BIOPLASTY, INC. REACHES TENTATIVE AGREEMENT TO SETTLE SHAREHOLDERS' SUIT
BIOPLASTY, INC. FILES FOR PROTECTION UNDER CHAPTER 11 OF THE U.S. BANKRUPTCY CODE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters